House passes legislation to enshrine a right to contraception in federal law

House passes legislation to enshrine a right to contraception in federal law


Representative Kathy Manning, a Democrat from North Carolina, speaks during an event ahead of the passage of H.R. 8373, the Right to Contraception Act, at the US Capitol in Washington, D.C., on Wednesday, July 20, 2022.

Al Drago | Bloomberg | Getty Images

WASHINGTON — The House voted Thursday to pass legislation to codify the right to contraception nationwide, seeking to protect it from potential Supreme Court intervention.

The Right To Contraception Act, sponsored by Rep. Kathy Manning, D-N.C., would establish a right in federal law for individuals to obtain and use contraceptives. It would also affirm a right for health care providers to provide contraceptives and allow the Justice Department and entities harmed by contraception restrictions to seek enforcement of the right in court.

Rep. Kathy Castor, R-Fla., said the United States is facing “a perilous time, where an extremist Supreme Court and the GOP are rolling back our rights.”

Democratic leaders said they were spurred to act by Justice Clarence Thomas’ concurring opinion in the ruling overturning Roe v. Wade, who wrote that the Supreme Court should also revisit decisions like 1965 Griswold v. Connecticut, which prohibited states from banning contraceptives and “correct the error” it made.

Rep. Ann Kuster, D-N.H., said the “overturning of Roe v. Wade was a wake up call” and that Congress could not leave other rights like that of contraception “up to chance,” saying it is “none of the government’s business.”

Most Republicans opposed the bill.

“Democrats are spreading fear and misinformation to score political points,” said Rep. Cathy McMorris Rodgers, R-Wash., the top Republican on the House Energy and Commerce Committee.

She called it “a Trojan horse for more abortions.”

The bill now goes to the Senate, where a companion version has been introduced by Sens. Ed Markey, D-Mass., Mazie Hirono, D-Hawaii, and Tammy Duckworth, D-Ill. But it’s unclear the measure will have the 60 votes required to break a likely Republican filibuster.

The legislation defines contraceptive as “any drug, device, or biological product intended for use in the prevention of pregnancy, whether specifically intended to prevent pregnancy or for other health needs, that is legally marketed under the Federal Food, Drug, and Cosmetic Act, such as oral contraceptives, long-acting reversible contraceptives, emergency contraceptives, internal and external condoms, injectables, vaginal barrier methods, transdermal patches, and vaginal rings, or other contraceptives.”

The vote came two days after the House voted to codify a right to same-sex marriage, with the support of 47 Republicans.

Rep. Debbie Lesko, R-Ariz., said Democrats were pursuing an “extreme abortion-on-demand agenda.”

Rep. Kat Cammack, R-Fla., said the bill violates “religious rights” and called it a bill by Democrats who invoke “states that they cannot name banning contraceptives.”‘

“Y’all are a real piece of work,” she said on the House floor.



Source

2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit
Health

2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit

The ripple is about to become a wave. Right now, there are numerous barriers for people who are considering treating their obesity with GLP-1 drugs. Early on, there were manufacturing bottlenecks that resulted in short supplies of Novo Nordisk ‘s Wegovy and Eli Lilly ‘s Zepbound. There were insurance coverage issues for these pricey treatments, […]

Read More
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More